AlgaHealth

What AlgaHealth does

AlgaHealth is an Israel-based, early-stage biotechnology company founded in 2017 and headquartered in Misgav, that is developing new microalgal sources for the production of high-quality fucoxanthin, a brown-seaweed-derived carotenoid used primarily in nutraceuticals, dietary supplements, and functional food and feed applications. The company's stated focus is on proprietary microalgal strains and bioprocess development to produce fucoxanthin at commercially relevant quality, with the implied technical differentiator being the use of microalgae rather than harvested wild seaweed as the production organism.

The company operates with a very small team (1-10 employees) and has raised approximately $1.41 million in disclosed funding across three rounds: a $660,000 seed from Trendlines Group in November 2017, a $750,000 round from Trendlines Group in March 2020, and a subsequent round from SPACE-F in March 2023. Its leadership includes CEO Eran Itzkovitch alongside co-founder Hagay Tzur and founder Oran Ayalon, indicating a founder-led management structure typical of venture-backed biotech startups.

There is no disclosed revenue, pricing model, customer base, product catalog, partnership, or commercial milestone in the available input data. The company's website (alga-health.com) currently displays a default cPanel hosting error page, indicating operational or technical issues that further limit visibility into the business. As a result, the company's go-to-market model, target customer segments, and revenue mechanics cannot be characterized from the evidence provided; the most defensible read is that AlgaHealth remains in a pre-commercial R&D stage focused on strain and bioprocess development.

Name

AlgaHealth

Website

https://alga-health.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

AlgaHealth is an Israel-based early-stage biotech developing proprietary microalgal strains for the production of high-quality fucoxanthin, a carotenoid used in nutraceuticals and functional ingredients. Founded in 2017, the company is pre-commercial and serves the specialty ingredient market.

Ownership category

akta.pro rank

Product category

Microalgae-derived nutraceutical ingredients

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol) (AFAJAKAI)

akta.pro secondary industries

Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF), Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids) (EUAAAIAL)

Keywords

• Microalgae cultivation
• Fucoxanthin production
• Algal biotechnology
• Natural pigment ingredients
• Nutraceutical raw materials

Headquarters

HQ city

Misgav

HQ country

Israel

HQ region

Middle East

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Supply Chain

Core offering

AlgaHealth develops new microalgal sources for the production of high-quality fucoxanthin, a naturally occurring carotenoid pigment with antioxidant properties. The company cultivates proprietary microalgal strains and applies bioprocessing techniques to produce fucoxanthin as an ingredient for industrial buyers in the nutraceutical, functional food, cosmetic, and pharmaceutical sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• Microalgae-derived fucoxanthin

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights2 records

Direct peers

• Algalif: Iceland-based producer of microalgae-based ingredients, notably astaxanthin from Haematococcus. Operates large-scale photobioreactor cultivation, sharing AlgaHealth's microalgae-platform DNA.
• Microphyt: French microalgae company that explicitly produces fucoxanthin (and other microalgal bioactives) for nutraceutical and cosmetic markets. Closest direct peer in terms of product, technology, and target customer base.
• Cyanotech Corporation: Hawaii-based producer of microalgae-derived natural products (spirulina, BioAstin astaxanthin). Direct peer in microalgae cultivation and natural carotenoid supply.
• Earthrise Nutritionals (Cargill): Large-scale spirulina (microalgae) producer now owned by Cargill. Compares to AlgaHealth on microalgae cultivation at industrial scale and natural-ingredient supply.
• Algatech (Solabia Group): Microalgae cultivator specializing in astaxanthin and other high-value microalgal ingredients for nutrition. Direct comparable in the microalgal specialty-ingredient category.

Broad incumbents

• DSM-Firmenich: Global ingredients giant producing carotenoids (including fucoxanthin-containing formulations) and nutritional lipids. Represents the at-scale incumbent that AlgaHealth would need to partner with or differentiate against.
• Kemin Industries: Specialty ingredient manufacturer with a strong carotenoid and natural-antioxidant portfolio for human and animal nutrition. Adjacent incumbent competing for the same specialty-ingredient wallet share.
• BASF (Nutrition & Health): Diversified chemical and ingredient company with a sizable carotenoid and natural-antioxidant portfolio. Comparable as a buyer/competitor for high-purity natural carotenoid ingredients.

Emerging players

• Photanol: Dutch microalgae-derived ingredient company using engineered cyanobacteria to produce specialty biochemicals. Comparable as a tech-forward microalgae platform targeting high-value ingredient applications.
• Parry Nutraceuticals (EID Parry): India-based producer of microalgae-derived nutraceuticals (spirulina, natural carotenoids). Comparable emerging supplier targeting similar B2B nutraceutical customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/algahealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AlgaHealth